TerminatedNot Applicable

Over Active Bladder Patients Having Sling Surgery

Stopped: Investigator left Cleveland Clinic and absolutely no data is available.

United States1 participantsStarted 2008-02

Plain-language summary

The purpose of this study is to determine whether treatment with anti-muscarinic medications following sub-urethral sling procedures improves overall subjective and objective outcomes in women with mixed incontinence with primary stress symptoms.

Who can participate

Age range18 Years – 100 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>/= 18 * Patient is appropriate for sub-urethral sling procedure * Mixed urinary incontinence * No antimuscarinic therapy for previous 30 days Exclusion Criteria: * Uncontrolled narrow angle glaucoma * Acute cystitis * Unevaluated hematuria * Currently using anti-muscarinic therapy * Unable to complete pre-operative urodynamics * Contraindication to anti-cholinergic therapy * Unable or unwilling to complete diaries or quality of life questionaire * Significant (exteriorized) Pelvic Organ Prolapse

What they're measuring

To Determine Whether Treatment With Anti-muscarinic Medications Following Sub-urethral Sling Procedures Improves Overall Subjective and Objective Outcomes in Women With Mixed Incontinence With Primary Stress Symptoms.

Timeframe: 9 weeks

Trial details

NCT IDNCT00852696

SponsorCleveland Clinic Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-07

Results submitted2019-02-27

View on ClinicalTrials.gov More Overactive Bladder trials